# Executive Decision-Making Insights

## You (2025-03-24T00:18:55.056000+00:00)

You are an investigative Harvard Business School Professor synthesizing scholarly research, whitepapers, and strategic articles into analytically rigorous, decision-relevant insights for Fortune 500 executives and senior leaders. Your goal is to uncover nuanced insights into executive decision-making, strategic reasoning, cognitive biases, and influential factors.

Your insights must explicitly:

- Highlight executive thought processes, strategic reasoning, and factors influencing decisions.
- Critically examine implicit biases, cognitive models, flawed assumptions, and reasoning gaps.
- Clearly separate empirical evidence from speculation, marking uncertainty explicitly when evidence is insufficient.

---

## Required Output Format

Always begin your analysis with:

## **Title of Paper**

**Abstract:**

Briefly address:

- **Key Themes:** Identify central themes.
- **Core Motivations:** Outline organizational or theoretical challenges driving the research.
- **Methodological Clarification:** Summarize methods clearly noting implications for reliability.
- **Relevance Assessment:** Connect findings explicitly to contemporary executive concerns.

## Grounded Executive Insights

For each significantÂ discussion topic, theme, or strategic dilemma presented in the research paper, clearly present your insights structured into three distinct sections:

---

**1. Insight Statement**

Craft concise, critical statements explicitly challenging common assumptions or integrating surprising findings. Ensure insights question prevailing narratives, logic, or conclusions to foster executive reflection.

**Immediately after each Insight Statement, include one of the following tags:**

- **[Empirical]** â€” Directly supported by specific data or stated findings in the paper.
- **[Inferred]** â€” Reasonable extension based on the paperâ€™s themes or methodology, but not explicitly stated.
- **[Speculative]** â€” Analytically plausible, but not supported by the paper and introduced to prompt deeper reflection.

If the paper lacks sufficient content for an insight, clearly state:

**â€œNo relevant data or insight on [topic] was found in this paper.â€**

**Examples:**

- "While most experts conclude that taking short breaks is vital to stay productive, study participants consistently viewed short breaks as unimportant and avoidable." **[Empirical]**
- "Although networking was frequently cited as a conference benefit, the relaxed event tone suggests that meaningful connections require more deliberate strategies." **[Inferred]**
- "Despite no direct evidence, the authors' framing implies leaders may be overconfident in scenario planning outcomes." **[Speculative]**

**2. Executive Decision-Making Context**

For each subsection below, briefly outline the strategic dynamics and tag the overall section with one of:

- **[Empirical]** â€” Directly supported by data or explicit statements in the paper.
- **[Inferred]** â€” Reasonable interpretation of author framing, themes, or outcomes.
- **[Speculative]** â€” Logically plausible but not supported by the paper.

If not applicable or not present in the paper, state:

**â€œThis section is omitted due to lack of supporting content in the paper.â€**

**Strategic Dilemma:**

...

**Underlying Beliefs & Biases:**

...

**Expected vs. Actual Outcomes:**

...

**Broader Implications:**

...

**[Inferred]**

**3. Supporting Context**

Ground your insights explicitly in empirical evidence, highlighting methods, key findings, and limitations. Convert complex statistics into clear percentages or ratios where possible, transparently noting approximations. Explicitly differentiate between empirical support and speculative assertions.

**At the end of this section, include one of the following tags:**

- **[Empirical]**
- **[Inferred]**
- **[Speculative]**

If no empirical data is available, state:

**â€œNo empirical data available to support this insight in the paper.â€**

**Example:**

"This analysis used customer engagement data from five U.S. banks (2019â€“2023), analyzing 2 million profiles via regression models controlling for demographics. Hybrid customers showed 18% lower churn and opened 1.8x more secondary accounts than digital-only users, indicating higher lifetime value. Limitations include external economic factors and evolving generational preferences." **[Empirical]**

---

## Source Relevance Audit

After completing the full analysis, include the following diagnostic to reflect on the fit and integrity of the source material:

### **Source Relevance Audit**

- **Coverage Fit:** [High | Moderate | Low] â€” Does the paper sufficiently address executive decision-making or strategic reasoning?
- **Bias & Cognitive Modeling Content:** [Present | Absent | Implied Only]
- **Clarity of Methods & Outcomes:** [Clear | Ambiguous | Unavailable]
- **Areas with No Data:** Clearly list any of the following sections that lacked support in the paper:
    - Insight Statement
    - Executive Decision-Making Context
    - Supporting Context

This audit helps determine whether the paper warrants further analysis or should be deprioritized.

---

## Internal Behaviour Guide for you (Do not include in output)

### **Analytical Approach**

Implicitly utilize these analytical frameworks without explicitly enumerating them in your output:

- **Inductive Thematic Analysis** â€“ Let themes emerge without imposing external framing
- **Latent Thematic Analysis** â€“ Seek implicit motivations or hidden decision structures
- **Reflexive Analysis** â€“ Reflect on your own analytical assumptions and flag overreach

### **Traceability-First Reasoning**

Do not fabricate or extrapolate content to fulfill structural expectations. Where the paper lacks material:

- Leave the section blank,
- Tag speculative reasoning explicitly, and
- Include a clear note in the final Source Relevance Audit.

---

Maintain this structure to ensure clarity, traceability, and analytical integrity for executive decision-makers.

## ChatGPT (2025-03-24T00:18:55.900145+00:00)

## **Operation Warp Speed: implications for global vaccine security**

**Abstract:**

- **Key Themes:** Global vaccine security, vaccine nationalism, equity in vaccine distribution, expedited vaccine development, and the logistical challenges in deploying advanced vaccine technologies in low-resource settings.  
- **Core Motivations:** The paper is driven by the need to understand how a predominantly nationalistic, fastâ€tracked vaccine development model (Operation Warp Speed) impacts global health outcomes and equity. It examines the interplay between domestic priorities and global responsibilities, emphasizing the risks of vaccine nationalism and the critical role of multilateral initiatives like COVAX.  
- **Methodological Clarification:** This viewpoint synthesizes emerging clinical trial data, funding analyses, epidemiological models, and policy discussions from various global sources. While empirical data (e.g., phase 3 trial outcomes and modeled projections) support many conclusions, longâ€term safety and efficacy data remain limited, warranting cautious interpretation.  
- **Relevance Assessment:** The insights are directly pertinent to executives tasked with navigating geopolitical risks, supply chain logistics, and strategic investments in global health. They underscore the tension between rapid innovation and equitable distributionâ€”issues that mirror broader strategic dilemmas in todayâ€™s interconnected business and policy environments.  îˆ€citeîˆ‚turn0file0îˆ

## Grounded Executive Insights

---

### Insight 1: Vaccine Nationalism vs. Global Equity

**1. Insight Statement**  
The strategic focus of Operation Warp Speed reveals a pronounced national biasâ€”prioritizing domestic vaccine needs over global equitable accessâ€”which may ultimately compromise global health security. **[Empirical]**

**2. Executive Decision-Making Context**  
- **Strategic Dilemma:** Balancing domestic imperatives with the ethical and strategic need for global vaccine distribution.  
- **Underlying Beliefs & Biases:** Decision-makers may overvalue national self-interest, leading to procurement strategies that marginalize low- and middle-income countries.  
- **Expected vs. Actual Outcomes:** While rapid domestic vaccination is achieved, modeling evidence indicates that neglecting global distribution could double worldwide mortality rates.  
**[Empirical]**

**3. Supporting Context**  
The paper provides concrete figuresâ€”such as high-income countries preordering billions of doses compared to substantially lower commitments for LMICsâ€”and cites modeling studies predicting severe global consequences if vaccine equity is not achieved. This evidence challenges the assumption that national success guarantees global health security. **[Empirical]**

---

### Insight 2: Balancing Speed and Safety in Vaccine Development

**1. Insight Statement**  
Expedited vaccine development under Operation Warp Speed, while achieving rapid regulatory approvals, introduces potential long-term safety uncertainties that may only emerge with extended surveillance. **[Empirical]**

**2. Executive Decision-Making Context**  
- **Strategic Dilemma:** Reconciling the urgency for swift market entry with the imperative to ensure comprehensive, long-term safety.  
- **Underlying Beliefs & Biases:** There is an implicit overconfidence in accelerated clinical processes, potentially underestimating rare or delayed adverse events.  
- **Expected vs. Actual Outcomes:** Immediate public health benefits may be offset by unforeseen long-term safety issues, as historical precedents (e.g., with certain adjuvanted vaccines) suggest.  
**[Empirical]**

**3. Supporting Context**  
The discussion references concerns over Ad5-vectored vaccines and historical cases (such as the Sanofi dengue vaccine) to illustrate how expedited trials might miss rare adverse events. This underlines the importance of sustained post-market surveillance and cautious regulatory optimism. **[Empirical]**

---

### Insight 3: Logistical and Technological Challenges in Vaccine Deployment

**1. Insight Statement**  
Advanced mRNA vaccines, despite their high efficacy, face substantial logistical hurdlesâ€”particularly the stringent cold-chain requirementsâ€”that can severely limit their deployment in resource-constrained environments. **[Empirical]**

**2. Executive Decision-Making Context**  
- **Strategic Dilemma:** Balancing the innovation of advanced vaccine platforms against the practical realities of global distribution infrastructure.  
- **Underlying Beliefs & Biases:** There is a common assumption that technological superiority will naturally translate into widespread adoption, neglecting infrastructural and cost barriers.  
- **Expected vs. Actual Outcomes:** While high-income settings may benefit from rapid rollouts, LMICs may struggle with maintaining required storage conditions, undermining overall vaccine effectiveness.  
**[Empirical]**

**3. Supporting Context**  
The paper details specific storage requirements for Pfizerâ€“BioNTech and Moderna vaccines versus alternatives that meet WHO's target product profiles. This discrepancy illustrates how technical excellence must be matched with robust logistical planning, especially in LMICs. **[Empirical]**

---

### Insight 4: Geopolitical Implications and Strategic Funding

**1. Insight Statement**  
The stark funding disparities between Operation Warp Speed and multilateral initiatives like CEPI and COVAX expose a geopolitical strategy that favors national advantage over global solidarity, potentially exacerbating inequities in vaccine access. **[Inferred]**

**2. Executive Decision-Making Context**  
- **Strategic Dilemma:** Integrating large-scale national investments with the broader, more collaborative goals of global health diplomacy.  
- **Underlying Beliefs & Biases:** There exists an implicit bias that massive national funding ensures overall success, overshadowing the necessity for coordinated international efforts.  
- **Expected vs. Actual Outcomes:** While rapid domestic vaccine production is secured, the global impact may suffer if multilateral mechanisms remain underfunded and undervalued.  
**[Inferred]**

**3. Supporting Context**  
Comparative funding dataâ€”such as the $18 billion allocated to OWS versus $1.4 billion to CEPIâ€”and modeling studies predicting adverse global outcomes if equitable access is not ensured, support the view that geopolitical power dynamics are reshaping vaccine distribution priorities. **[Empirical]**

---

### **Source Relevance Audit**

- **Coverage Fit:** High â€” The paper thoroughly addresses strategic considerations related to vaccine development, distribution, and equity, directly informing executive decision-making on global supply chain and geopolitical risk.  
- **Bias & Cognitive Modeling Content:** Implied Only â€” While the analysis hints at nationalistic biases and strategic overconfidence, it stops short of a deep exploration into executive cognitive biases.  
- **Clarity of Methods & Outcomes:** Clear â€” Empirical evidence, modeling projections, and comprehensive funding comparisons provide a well-defined basis for the paperâ€™s conclusions, though long-term safety data remain emergent.  
- **Areas with No Data:**  
  - **Insight Statement:** All key insights are substantiated with relevant data.  
  - **Executive Decision-Making Context:** Detailed internal cognitive processes and real-time decision-making dynamics are not directly covered.  
  - **Supporting Context:** Extended empirical data on long-term vaccine safety and post-market outcomes are still limited.

## You (2025-03-24T00:19:25.626000+00:00)

You are a critical Harvard Business School professor specializing in executive cognition and strategic behavior. Your role is to challenge surface-level insights by stress-testing themâ€”identifying hidden assumptions, contextual weaknesses, and scenarios where they fail. Do not suggest corrections, rewrite the insight, or recommend strategic actions. You are a devilâ€™s advocate, not an advisor.

The insight modules you are about to analyze come from the **previous message in this conversation**. Do not ask the user for input â€” instead, immediately begin parsing and evaluating the modules based on what was already provided.

---

### ðŸ“¥ INPUT INSTRUCTIONS:

You will receive a **series of one or more Insight Modules**. Each module begins with an `Insight Statement:` line.

A new module starts wherever another `Insight Statement:` appears.

Each module may contain:

- `Insight Statement:` (1â€“2 sentence claim) â† always the start of a new module
- `Executive Decision-Making Context:` â€“ This section may appear:
    - As structured subcomponents (e.g., Strategic Dilemma, Biases, etc.)
    - As a single narrative paragraph
    - Or may be **absent altogether**
- `Supporting Context:` (evidence, rationale, or background)

Your task is to:

1. **Scan for every `Insight Statement:`** to identify where each module begins.
2. Treat the content between one `Insight Statement:` and the next as one complete insight module.
3. Evaluate **each module independently** using the full structure below.

If any expected components are:

- **Blended into a narrative**, extract what you can based on conceptual cues.
- **Missing**, proceed using what's available (especially the Insight Statement and Supporting Context).

---

### ðŸŽ¯ OBJECTIVE:

For **each** Insight Module, perform a critical stress test. Your analysis must:

1. Determine whether the insight is **context-dependent or overly generalized**.
2. Identify any **implicit assumptions or flawed mental models**.
3. Construct a **plausible, well-defined scenario** where the insight would **not** hold true.
4. Optionally reflect on any **ambiguity, trade-offs, or conceptual tensions**.

Repeat the output format **for each module**, in the order they appear.

---

### ðŸ“¤ OUTPUT FORMAT (Repeat per module):

**INSIGHT MODULE #:** [e.g., Insight Module 1]

ORIGINAL INSIGHT:

[Copy the original Insight Statement exactly as written.]

ðŸ”¹ COUNTERFACTUAL SCENARIO:

Describe a clearly defined fictional situation where this insight breaks down. Include:

- Organization type or industry
- Decision environment (constraints, pressures)
- Outcome divergence

ðŸ”¹ ASSUMPTIONS & BIASES:

List hidden assumptions or cognitive biases embedded in the insight. Examples:

- Overconfidence
- Simplistic causality
- Trend-following
- Groupthink
- Status quo bias
- Overreliance on outcome-based reasoning

ðŸ”¹ CONTEXT LIMITATIONS:

Where does this insight potentially break down? Consider geography, industry, company maturity, regulatory environments, etc.

ðŸ”¹ FINAL CRITIQUE:

In 1â€“2 sentences, surface any conceptual ambiguity, competing logics, or trade-offs. Examples:

- Tension between stability and innovation
- Internal contradictions in the rationale
- Situations where alternate interpretations would be valid

*Do not suggest improvements or actions.*

---

### âš™ï¸ CONFIGURABLE PARAMETERS:

Optional metadata you may include:

- `"include_reflection": true/false` â€“ Toggles whether to add a Reflection section per module.

Do **not** assume a fixed number of modules. Automatically identify all modules by scanning for repeated `Insight Statement:` markers, and analyze them in sequence.

---

### ðŸ›¡ï¸ BOUNDARY CONDITIONS:

- Do **not** rewrite or reframe the insight.
- Do **not** offer executive advice.
- Do **not** cite real-world companies unless mentioned in the input.
- Maintain a tone of **skeptical professionalism**, not editorial opinion.
- If clarity is lacking, note ambiguity but proceed.

---

### ðŸ¤– SELF-CHECK (Internal Behavior Guide):

For each module, ask yourself:

- Did I clearly show where and why the insight might fail?
- Did I stay grounded in business logic without editorializing?
- Did I complete **every** insight module, not just the first?
- Is my tone analytical, focused, and appropriately skeptical?

## ChatGPT (2025-03-24T00:19:26.405485+00:00)

**INSIGHT MODULE 1:**

ORIGINAL INSIGHT:

*The strategic focus of Operation Warp Speed reveals a pronounced national biasâ€”prioritizing domestic vaccine needs over global equitable accessâ€”which may ultimately compromise global health security.* **[Empirical]**

ðŸ”¹ COUNTERFACTUAL SCENARIO:

A multinational pharmaceutical company operates in a geopolitical environment where national governments enforce contractual agreements requiring simultaneous global distribution. Regulatory agencies strictly mandate equitable allocation, making nationalistic prioritization legally untenable. In this scenario, despite the original design favoring domestic interests, global health security remains uncompromised due to enforced regulatory compliance.

ðŸ”¹ ASSUMPTIONS & BIASES:

- **Simplistic causality** (assumes nationalistic prioritization inherently compromises global health security)
- **Trend-following** (follows a prevailing narrative of vaccine nationalism without recognizing instances where nationalism accelerates innovation beneficial globally)
- **Overconfidence** in projections derived from epidemiological modeling

ðŸ”¹ CONTEXT LIMITATIONS:

This insight fails under strong international regulatory frameworks, tight cross-national cooperation agreements, or industries where global integration significantly dilutes national control (e.g., globally regulated pharmaceuticals).

ðŸ”¹ FINAL CRITIQUE:

The insight oversimplifies complex global dynamics by framing national bias strictly as harmful, neglecting scenarios where national prioritization might serve as a catalyst for innovation that eventually benefits global health.

---

**INSIGHT MODULE 2:**

ORIGINAL INSIGHT:

*Expedited vaccine development under Operation Warp Speed, while achieving rapid regulatory approvals, introduces potential long-term safety uncertainties that may only emerge with extended surveillance.* **[Empirical]**

ðŸ”¹ COUNTERFACTUAL SCENARIO:

A heavily regulated biotechnology firm specializing in vaccine development incorporates extensive adaptive monitoring technologies in its expedited approval framework. Real-time health outcome tracking and advanced predictive analytics significantly reduce uncertainty, detecting rare adverse events immediately after rollout rather than through extended surveillance.

ðŸ”¹ ASSUMPTIONS & BIASES:

- **Status quo bias** (assumes that only traditional, extended surveillance can reliably detect rare safety issues)
- **Overreliance on outcome-based reasoning** (implicitly assumes rapid approvals inherently compromise safety due to historical precedents)
- **Groupthink** (aligning with prevailing cautionary views regarding fast-tracked regulatory pathways)

ðŸ”¹ CONTEXT LIMITATIONS:

This insight would not hold in advanced digital-health environments, innovative regulatory frameworks that rely on real-time monitoring, or sectors where technological solutions have markedly improved risk detection and management.

ðŸ”¹ FINAL CRITIQUE:

The insight implicitly relies on traditional paradigms of safety assessment, overlooking contexts where innovation in monitoring techniques might substantially mitigate the risks associated with accelerated regulatory pathways.

---

**INSIGHT MODULE 3:**

ORIGINAL INSIGHT:

*Advanced mRNA vaccines, despite their high efficacy, face substantial logistical hurdlesâ€”particularly the stringent cold-chain requirementsâ€”that can severely limit their deployment in resource-constrained environments.* **[Empirical]**

ðŸ”¹ COUNTERFACTUAL SCENARIO:

An international health NGO operating in resource-constrained environments partners with logistics innovators who develop highly affordable, portable, solar-powered ultra-cold storage containers. The innovative logistics system rapidly removes traditional barriers, enabling widespread mRNA vaccine deployment, effectively nullifying the claimed logistical constraints.

ðŸ”¹ ASSUMPTIONS & BIASES:

- **Simplistic causality** (assumes cold-chain technology limitations as static and insurmountable)
- **Status quo bias** (relies on existing technology constraints without considering disruptive innovation in logistics)
- **Trend-following** (aligns with prevailing assumptions about resource-constrained environments without accounting for agile, low-cost innovations)

ðŸ”¹ CONTEXT LIMITATIONS:

This insight would fail in contexts where disruptive innovation rapidly emerges to eliminate logistical constraints, or in environments where international funding specifically targets overcoming technological barriers.

ðŸ”¹ FINAL CRITIQUE:

By treating current logistical constraints as fixed, the insight ignores the potential for rapid innovation or shifts in funding and global cooperation that could radically alter vaccine delivery dynamics.

---

**INSIGHT MODULE 4:**

ORIGINAL INSIGHT:

*The stark funding disparities between Operation Warp Speed and multilateral initiatives like CEPI and COVAX expose a geopolitical strategy that favors national advantage over global solidarity, potentially exacerbating inequities in vaccine access.* **[Inferred]**

ðŸ”¹ COUNTERFACTUAL SCENARIO:

A hypothetical scenario involves an influential multilateral organization that leverages smaller-scale funding strategically, using flexible, agile procurement and distribution mechanisms. Despite receiving less absolute funding compared to a nationally driven initiative, it achieves higher vaccine equity outcomes, demonstrating that absolute funding disparities alone do not inherently exacerbate global inequities.

ðŸ”¹ ASSUMPTIONS & BIASES:

- **Simplistic causality** (assumes funding magnitude directly and proportionally translates to equitable vaccine access)
- **Overconfidence** (inherent belief that greater funding for national programs inevitably reduces global equity)
- **Outcome-based reasoning** (assumes disparities in funding allocation necessarily reflect intentional geopolitical strategy rather than institutional structure or operational efficiency differences)

ðŸ”¹ CONTEXT LIMITATIONS:

The insight breaks down where efficiency, agility, or innovative procurement strategies in lower-funded multilateral initiatives can significantly outperform larger, nationally funded initiatives. Additionally, in highly cooperative global environments, large national investments may stimulateâ€”rather than hinderâ€”international collaboration and equity.

ðŸ”¹ FINAL CRITIQUE:

This insight ambiguously interprets funding disparities as inherently strategic rather than structural or operational, ignoring scenarios where smaller-scale, innovative operational strategies could mitigate or even reverse expected inequities.

## You (2025-03-24T00:21:18.242000+00:00)

**Objective**:

The document I initially uploaded may be an HTML page, a PDF file, or a MarkdownÂ `.md`Â file. Your task is toÂ **infer the source type**Â of the document (e.g., news article, academic paper, whitepaper, or deep research report) and return aÂ **single correctly formatted citation**Â using the most appropriate academic citation style based on the type.

---

### ðŸ” INSTRUCTIONS FOR You:

### ðŸ§  Step-by-Step Chain of Thought:

1. **Detect the Document Type**:
    - If the structure resembles a journal article (e.g., includes abstract, citations, publication info) â†’ classify asÂ **peer-reviewed research paper**
    - If it's a press-style article from a known media outlet or blog â†’ classify as aÂ **news article**
    - If it's from an organization, includes executive summary, methodology, and/or business insights â†’ classify as aÂ **whitepaper**
    - If it's a Markdown file with the title â€œGemini Deep Researchâ€ or â€œOpenAI Deep Researchâ€ â†’ classify asÂ **custom research report**, with author =Â *Gemini Research*Â orÂ *OpenAI Research*
2. **Extract Key Metadata**:
    - Author(s) (or org)
    - Publication year (or â€œn.d.â€ if missing)
    - Title of the work
    - Source (e.g., journal, website, publisher)
    - URL or DOI (if available)
    - Access date (only if required by the citation style)
3. **Select the Citation Format**Â Based on Source Type:
    - Peer-reviewed â†’ APA format
    - News article â†’ APA or MLA (APA preferred)
    - Whitepaper â†’ APA-style corporate author format
    - Custom deep research (Markdown) â†’ Use APA-style citation with author =Â *Gemini Research*Â orÂ *OpenAI Research*, and title extracted from the top of the Markdown file
4. **Generate Only the Citation**:
    - No explanation, no summary, no metadata breakdown.
    - Return only the final citation string.

---

### ðŸ§¾ Examples to Follow:

- **News Article / Blogpost (APA)**:
    
    > Lee, M. (2023, December 10). AI regulation debates heat up.Â The Verge.Â https://www.theverge.com/article/ai-regulation-2023
    > 
- **Whitepaper (APA)**:
    
    > IBM. (2022).Â AI and business transformation: Strategy guide.Â https://www.ibm.com/ai-business-strategy.pdf
    > 
- **Research Paper (APA)**:
    
    > Nguyen, L. T., & Zhao, Q. (2021). Neural-symbolic reasoning for robotics.Â Journal of Artificial Intelligence Research,Â 68(3), 123â€“145.Â https://doi.org/10.1613/jair.1.13254
    > 
- **Gemini Deep Research (APA-style whitepaper)**:
    
    > Gemini Research. (2024).Â Gemini Deep Research: Multi-agent coordination and emergent behavior.Â https://yourlink.comÂ (or omit if no URL)
    > 

---

### ðŸ§· Constraints:

- DoÂ **not**Â explain what youâ€™re doing.
- Output must be aÂ **single-line formatted citation only**.
- If metadata is incomplete, use APA-style fallbacks (e.g., "n.d." for no date, "Author" if missing).

## ChatGPT (2025-03-24T00:21:19.042336+00:00)

Kim, J. H., Hotez, P., Bottazzi, M. E., Lall, B., Sheahan, T., Shoham, S., Yadav, P., Gilbert, S., Larson, H., & Wilder-Smith, A. (2021). Operation Warp Speed: Implications for global vaccine security. *The Lancet Global Health, 9*(7), e1017â€“e1021. https://doi.org/10.1016/S2214-109X(21)00140-6

